Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ovagene Oncology
AddedFeb 16, 2024
UpdatedJun 18, 2026
Ovagene Oncology

Ovagene Oncology

Public

OvaGene: A revenue-growth firm specializing in developing and commercializing women's molecular diagnostics.

HQ
Irvine, CA, US
Founded
2010
Overview
Compare
Fundraising
Employees

OvaGene Oncology is a molecular diagnostics company focused on developing and commercializing innovative diagnostic solutions for women's health. The company's mission is to enhance patient care through advanced molecular diagnostics, targeting conditions specific to women. OvaGene aims to provide accurate, timely, and actionable insights to improve treatment outcomes and overall health.

OvaGene has achieved significant growth and revenue milestones, establishing itself as a leader in the women's molecular diagnostics market. The company's impact is evident in its successful commercialization of cutting-edge diagnostic tools that aid in early detection and personalized treatment plans.

Ovagene Oncology - Similar Companies

Oncocyte logo

Oncocyte

oncocyte.com

Nanopath logo

Nanopath

nanopathdx.com

Aspira Women's Health logo

Aspira Women's Health

aspirawh.com

Myriad Genetics logo

Myriad Genetics

myriad.com

OncoHealth logo

OncoHealth

oncohealthcorp.com

Foundation Medicine logo

Foundation Medicine

UE LifeSciences logo

UE LifeSciences

uelifesciences.com

Biomirror Diagnostics logo

Biomirror Diagnostics

Genendeavor logo

Genendeavor

genendeavor.com

HTG Molecular Diagnostics logo

HTG Molecular Diagnostics

htgmolecular.com

Avant Diagnostics logo

Avant Diagnostics

Molecular Detection logo

Molecular Detection

Genevolve Vision Diagnostics logo

Genevolve Vision Diagnostics

Mammogen logo

Mammogen

mammogen.bio

CancerGuide Diagnostics logo

CancerGuide Diagnostics

Ovagene Oncology - Quick Facts

Who are Ovagene Oncology's competitors?

Companies similar to Ovagene Oncology include Oncocyte, Nanopath, Aspira Women's Health and Myriad Genetics.

When was Ovagene Oncology founded?

Ovagene Oncology was founded in 2010.

Where is Ovagene Oncology's headquarters located?

Ovagene Oncology's headquarters is located in Irvine, CA, US.

How much has Ovagene Oncology raised to-date?

As of Oct 20, 2013, Ovagene Oncology has raised a total of $2.1M (USD).

How many employees does Ovagene Oncology have?

Ovagene Oncology has 11 employees as of Feb 5, 2024.

Ovagene Oncology - Classification

Ownership
  • Public
Technology
  • Analytics
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Molecular Diagnostics
Tags
  • Biotech
  • Data Information
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified